1st Circ. Sides With J&J Subsidiary In Lactaid False Ad Suit
The First Circuit on Monday affirmed the dismissal of a proposed class action alleging that a Johnson & Johnson subsidiary misbrands its Lactaid drug products as dietary supplements, holding that federal...To view the full article, register now.
Already a subscriber? Click here to view full article